Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 1 | — | — |
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 2 | — | — |
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | 3 | — | — |
pneumonia sepsis; pneumonia sepsis; This spontaneous report was received from an Other health professional (HCP) via field employee and refers to a Child male patient of unknown age. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On an unknown dates, the patient was vaccinated 3 doses of Pneumococcal 15-valent Conjugate Vaccine (VAXNEUVANCE) Suspension for injection, (indication, expiration date, and lot # were not reported) for prophylaxis. Reporter said that after the third dose the child developed pneumonia sepsis. This happened last year (in approximately 2024), the HCP did not have an exact date and the nurse who worked with the child was not available. Child was hospitalized. At the reporting time, the outcome of pneumonia sepsis was unknown. The causal relationship between the event of pneumonia sepsis and Pneumococcal 15-valent Conjugate Vaccine was not provided.